Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2041362
Max Phase: Preclinical
Molecular Formula: C28H21NO4S
Molecular Weight: 467.55
Molecule Type: Small molecule
Associated Items:
ID: ALA2041362
Max Phase: Preclinical
Molecular Formula: C28H21NO4S
Molecular Weight: 467.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=S(=O)(Nc1cccc(-c2c(O)ccc3cc(-c4cccc(O)c4)ccc23)c1)c1ccccc1
Standard InChI: InChI=1S/C28H21NO4S/c30-24-9-5-6-19(18-24)20-12-14-26-21(16-20)13-15-27(31)28(26)22-7-4-8-23(17-22)29-34(32,33)25-10-2-1-3-11-25/h1-18,29-31H
Standard InChI Key: JLXZFOKLMHPLGF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 467.55 | Molecular Weight (Monoisotopic): 467.1191 | AlogP: 6.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 86.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.80 | CX Basic pKa: | CX LogP: 6.14 | CX LogD: 6.01 |
Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.28 | Np Likeness Score: -0.44 |
1. Henn C, Einspanier A, Marchais-Oberwinkler S, Frotscher M, Hartmann RW.. (2012) Lead optimization of 17β-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis., 55 (7): [PMID:22380653] [10.1021/jm201735j] |
Source(1):